Yahoo Web Search

Search results

    • Q1 2024 Organogenesis Holdings Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 5 days ago

      Turning to an update on our progress on our ReNu programs. Our ongoing Phase 3 clinical trial evaluating the use of ReNu for the management of symptoms associated with knee